2022
DOI: 10.1097/md.0000000000029272
|View full text |Cite
|
Sign up to set email alerts
|

Retrospective study assessing the efficacy of i.v. dexamethasone, SNRB, and nonsteroidal treatment for radiculopathy

Abstract: Retrospective study.The purpose of this study was to investigate the clinical symptomatology of discopathies before and 7 days after treatment with one of the following: intravenous dexamethasone, selective nerve root block (SNRB), and systemic treatment with different nonsteroidal antiinflammatory drugs (NSAIDs).Radiculopathy is a clinical condition in which dysfunction of one or more nerves occurs due to mechanical compression and/ or chemical irritation of the nerve roots. Most often located in the lumbar s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 30 publications
0
2
0
Order By: Relevance
“…Some have shown a short-term advantage [ 23 , 24 ], while others have not shown any value [ 4 ]. The rationale for intravenous (IV) glucocorticoid administration in acute sciatica is rapid delivery of high-level glucocorticoids that reduce the inflammatory cascade caused by the HNP without the discomfort and dangers of epidural injection and allow an easy and accessible treatment as SNRB availability varies between countries and health systems [ 25 , 26 , 27 ]. Previous studies suggested that IV administration has a better risk–benefit ratio than other methods of treatment [ 28 , 29 ]; still, recent publications showed limited effect [ 12 , 30 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Some have shown a short-term advantage [ 23 , 24 ], while others have not shown any value [ 4 ]. The rationale for intravenous (IV) glucocorticoid administration in acute sciatica is rapid delivery of high-level glucocorticoids that reduce the inflammatory cascade caused by the HNP without the discomfort and dangers of epidural injection and allow an easy and accessible treatment as SNRB availability varies between countries and health systems [ 25 , 26 , 27 ]. Previous studies suggested that IV administration has a better risk–benefit ratio than other methods of treatment [ 28 , 29 ]; still, recent publications showed limited effect [ 12 , 30 ].…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies suggested that IV administration has a better risk–benefit ratio than other methods of treatment [ 28 , 29 ]; still, recent publications showed limited effect [ 12 , 30 ]. Despite numerous publications regarding IV glucocorticoid administration in ALRP, the role and efficacy of this treatment remain undetermined without an agreed single treatment protocol or dosage showing superiority [ 25 ].…”
Section: Introductionmentioning
confidence: 99%